Agenus (AGEN) Posts Q1 Loss of 28c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/14/2026

1. NVDA
2. DPZ
3. DRS
4. GS
5. BAC
6. UNH
7. ORCL
8. AVAV
9. ACI
10. META

Go back to Agenus (AGEN) Posts Q1 Loss of 28c/Share

Agenus Reports First Quarter 2015 Financial Results

April 23, 2015 7:00 AM EDT

Corporate Update Conference Call at 11 am ET Today

Agenus to Host R&D Day in New York, NY on May 14

LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc. (NASDAQ: AGEN), an immunotherapy company developing immune-oncology checkpoint modulators (CPMs) and heat shock protein peptide-based vaccines as well as immune adjuvants, today announced its financial results for the first quarter ended March 31, 2015.

We began the year by establishing a strategic alliance with Incyte, focused on the development of novel cancer treatments targeting immune checkpoints. During the... More